Skip to content
healthcare.dev

Bromocriptine mesylate

NDC 68382-110, Bromocriptine mesylate, capsule, from Zydus Pharmaceuticals USA Inc..

Product NDC
68382-110
Status
Listed
Labeler
Zydus Pharmaceuticals USA Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078899
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68382-110 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BROMOCRIPTINE MESYLATE5 mg/1

Pharmacologic classes

Ergolines [CS]; Ergot Derivative [EPC]

Package NDCNDC-11Package
68382-110-0168382011001100 CAPSULE in 1 BOTTLE (68382-110-01)
68382-110-066838201100630 CAPSULE in 1 BOTTLE (68382-110-06)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d69003ee-0b6f-47a9-834e-ba59c02f566c
  • NADAC price for package 68382011006

    GET /v1/drugs/nadac/68382011006

Use it

Look up 68382-110 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68382-110 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68382-110. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.